ADAP
Adaptimmune Therapeutics
ADAP
ADAP
47 hedge funds and large institutions have $260M invested in Adaptimmune Therapeutics in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 7 closing their positions.
Holders
47
Holders Change
-2
Holders Change %
-4.08%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
5
Increased
10
Reduced
14
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
Adage Capital Partners
Boston,
Massachusetts
|
$12.6M |
2 |
O
2
OrbiMed
New York
|
$5.9M |
3 |
RG
3
Rathbones Group
Liverpool,
United Kingdom
|
$3.67M |
4 |
AC
4
Ascend Capital
Orinda,
California
|
$1.75M |
5 |
NLVP
5
New Leaf Venture Partners
New York
|
$1.04M |